Media coverage
20
Media coverage
Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet PipelineReview Country Spain Date 4/14/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Plus Company Updates (PCU) Country United States Date 4/14/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet PR Newswire Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Morningstar.com Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet PR Newswire Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Canada NewsWire Country Canada Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Canada NewsWire Country Canada Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet PR Newswire Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet WorldNetDaily Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet BioSpace Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Yahoo! Finance Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet PharmiWeb Country United Kingdom Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Biotechgate Country Switzerland Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet India Pharma News Country India Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet USA Life Sciences Database Country Switzerland Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet Pharmacy Choice Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet PharmaVOICE Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet KMOV.com Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet WOWK Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd Title Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial Media name/outlet KTVN Country United States Date 4/13/17 Persons Andrew Brenner, John R Floyd